Page 101 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

80 PART I The Biology and Pathogenesis of Cancer

195. Koenig A, Wojcieszyn J, Weeks BR, et al.: Expression of S100a, 205. Beck J, Miller MA, Frank C, et al.: Surfactant protein A and napsin
vimentin, NSE, and melan A/MART-1 in seven canine melanoma A in the immunohistochemical characterization of canine pulmo-
cells lines and twenty-nine retrospective cases of canine melanoma, nary carcinomas: comparison with thyroid transcription factor-1,
VetBooks.ir 196. Giudice C, Ceciliani F, Rondena M, et al.: Immunohistochemical 206. Andreasen CB, White MR, Swayne DE, et al.: Desmin as a marker
Vet Pathol 38:427–435, 2001.
Vet Pathol 54:767–774, 2017.
investigation of PNL2 reactivity of canine melanocytic neoplasms
1988.
and comparison with Melan A, J Vet Diagn Invest 22:389–394, 2010. for canine botryoid rhabdomyosarcomas, J Comp Pathol 98:23–29,
197. Ramos-Vara JA, Miller MA: Immunohistochemical identification 207. Murakami M, Sakai H, Iwatani N, et al.: Cytologic, histologic,
of canine melanocytic neoplasms with antibodies to melanocytic and immunohistochemical features of maxillofacial alveolar rhab-
antigen PNL2 and tyrosinase: comparison with Melan A, Vet Pathol domyosarcoma in a juvenile dog, Vet Clin Pathol 39:113–118,
48:443–450, 2011. 2010.
198. Ramos-Vara JA, Miller MA, Johnson GC, et al.: Melan A and S100 208. Caserto BG: A comparative review of canine and human rhabdo-
protein immunohistochemistry in feline melanomas: 48 cases, Vet myosarcoma with emphasis on classification and pathogenesis, Vet
Pathol 39:127–132, 2002. Pathol 50:806–826, 2013.
199. McDonough SP, MacLachlan NJ, Tobias AH: Canine pericardial 209. Fairley R: Synovial tumors in dogs, Vet Pathol 39:413–414, 2002.
mesothelioma, Vet Pathol 29:256–260, 1992. 210. Criag LE, Thompson KG: Tumors of the joint. In Meuten D,
200. Lipsitz D, Higgins RJ, Kortz GD, et al.: Glioblastoma multiforme: editor: Tumors in domestic animals, ed 5, Ames, Iowa, 2017, John
clinical findings, magnetic resonance imaging, and pathology in Wiley & Sons, Inc, pp 337–345.
five dogs, Vet Pathol 40:659–669, 2003. 211. Liptak JM, Kamstock DA, Dernell WS, et al.: Cranial mediastinal
201. Stoica G, Kim HT, Hall DG, et al.: Morphology, immunohisto- carcinomas in nine dogs, Vet Comp Oncol 6:19–30, 2008.
chemistry, and genetic alterations in dog astrocytomas, Vet Pathol 212. Ramos-Vara JA, Miller MA, Johnson GC, et al.: Immunohisto-
41:10–19, 2004. chemical detection of thyroid transcription factor-1, thyroglobu-
202. Kovi RC, Wunschmann A, Armien AG, et al.: Spinal meningeal oligo- lin, and calcitonin in canine normal, hyperplastic, and neoplastic
dendrogliomatosis in two boxer dogs, Vet Pathol 50:761–764, 2013. thyroid gland, Vet Pathol 39:480–487, 2002.
203. Ferreira-Neves P, Lezmi S, Lejeune T, et al.: Immunohistochemical 213. Ramos-Vara JA, Miller MA, Johnson GC: Usefulness of thyroid
characterization of a hepatic neuroendocrine carcinoma in a cat, transcription factor-1 immunohistochemical staining in the differ-
J Vet Diagn Invest 20:110–114, 2008. ential diagnosis of primary pulmonary tumors of dogs, Vet Pathol
204. Ramos-Vara JA, Miller MA, Valli VE: Immunohistochemical detec- 42:315–320, 2005.
tion of multiple myeloma 1/interferon regulatory factor 4 (MUM1/
IRF-4) in canine plasmacytoma: comparison with CD79a and CD20,
Vet Pathol 44:875–884, 2007.